These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3710608)

  • 1. Toxic epidermal necrolysis with extensive mucosal erosions of the gastrointestinal and respiratory tracts.
    Roupe G; Ahlmén M; Fagerberg B; Suurküla M
    Int Arch Allergy Appl Immunol; 1986; 80(2):145-51. PubMed ID: 3710608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis, toxic epidermal necrolysis and pancreatitis in association with sulindac therapy.
    Klein SM; Khan MA
    J Rheumatol; 1983 Jun; 10(3):512-3. PubMed ID: 6224935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
    Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
    Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic epidermal necrolysis in Stevens--Johnson syndrome.
    Assaad D; From L; Ricciatti D; Shapero H
    Can Med Assoc J; 1978 Jan; 118(2):154-6. PubMed ID: 757383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation.
    de Prost N; Mekontso-Dessap A; Valeyrie-Allanore L; Van Nhieu JT; Duong TA; Chosidow O; Wolkenstein P; Brun-Buisson C; Maître B
    Crit Care Med; 2014 Jan; 42(1):118-28. PubMed ID: 23989174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leflunomide-induced toxic epidermal necrolysis in a patient with rheumatoid arthritis.
    Hassikou H; El Haouri M; Tabache F; Baaj M; Safi S; Hadri L
    Joint Bone Spine; 2008 Oct; 75(5):597-9. PubMed ID: 18805724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stevens-Johnson syndrome and toxic epidermal necrolysis from pathologist's point of view.
    Sticová E; Kyclová J; Důra M; Štork J; Lipový B
    Cesk Patol; 2023; 59(3):124-128. PubMed ID: 37805268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Leflunomide-induced toxic epidermal necrolysis].
    El Aïdli S; Salouage I; Kastalli S; Srairi S; Daghfous R; Loueslati MH; Belkahia C
    Therapie; 2008; 63(2):157-8. PubMed ID: 18677817
    [No Abstract]   [Full Text] [Related]  

  • 9. Sulindac-induced Stevens-Johnson toxic epidermal necrolysis syndrome.
    Levitt L; Pearson RW
    JAMA; 1980 Mar; 243(12):1262-3. PubMed ID: 7359684
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acute onset Hodgkin's disease following Lyell's syndrome].
    Marque M; Girard C; Bessis D; Guillot B
    Ann Dermatol Venereol; 2007 Oct; 134(10 Pt 1):767-70. PubMed ID: 17978717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of toxic epidermal necrolysis secondary to indomethacin.
    O'Sullivan M; Hanly JG; Molloy M
    Br J Rheumatol; 1983 Feb; 22(1):47-9. PubMed ID: 6824826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome/toxic epidermal necrolysis by immunohistopathological features.
    Cho YT; Lin JW; Chen YC; Chang CY; Hsiao CH; Chung WH; Chu CY
    J Am Acad Dermatol; 2014 Mar; 70(3):539-48. PubMed ID: 24388722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clues to pathogenesis of toxic epidermal necrolysis.
    Merot Y; Saurat JH
    Int J Dermatol; 1985 Apr; 24(3):165-8. PubMed ID: 3888879
    [No Abstract]   [Full Text] [Related]  

  • 16. Toxic epidermal necrolysis localized to an area of lymphoedema.
    Wilkinson SM; Heagerty AH; Smith AG
    Clin Exp Dermatol; 1992 Nov; 17(6):456-7. PubMed ID: 1486718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.
    Roujeau JC; Kelly JP; Naldi L; Rzany B; Stern RS; Anderson T; Auquier A; Bastuji-Garin S; Correia O; Locati F
    N Engl J Med; 1995 Dec; 333(24):1600-7. PubMed ID: 7477195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus.
    Saiag P; Caumes E; Chosidow O; Revuz J; Roujeau JC
    J Am Acad Dermatol; 1992 Apr; 26(4):567-74. PubMed ID: 1597543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.